Pressure Biosciences Inc (OTCQB:PBIO) is a company that is best known for the manufacturing of broadly enabling pressure-based instruments. Additionally, the company has also come up with its own Ultra Shear Platform. The platform can help in boosting the efficacy of cosmetics, medicines, vitamins and other health-related products through higher molecular absorption.

Health related products are often sold with instructions on labels to users to ‘shake’ before use. However, the technology from Pressure Biosciences helps in the creation of invisibly solubilized nanoemulsions particles of oil in water and as a result, no shaking is necessary. The company had recently gone into a partnership with CBD Supply MD, which is a major supplier of CBD products in the mid-Atlantic region across a number of states.

The company was in the news yesterday after it announced that a third round of consumer focus group testing had been conducted of the THC Nanoemulsion Oral Spray that had been designed for fast and rapid absorption by way of the cheeks and the tongue.

The product had been created through the deployment of the company’s Ultra Shear Technology platform. It had been created by one of Pressure Biosciences’ partner companies based in California Crème De Canna, a licensed manufacturer in California which holds an established record in providing high-quality products to the cannabis market.

An extra 25 more consumers were part of the on-going focus group testing and that brought the total number of participants to 60 up until yesterday. In the focus group study, it was noted that the participants had affirmed the key attributes that had differentiated Ultra Shear Technology produced products from another method of manufacturing. It was a major new development for Pressure Biosciences and one that could bring the stock into focus today.